日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine

IL-6/STAT3信号通路在CD4+FOXP3- T细胞中的调节是阿扎胞苷潜在的抗肿瘤机制。

Lamprianidou, Eleftheria; Kordella, Chryssoula; Kazachenka, Anastasiya; Zoulia, Emmanouela; Bernard, Elsa; Filia, Anastasia; Laidou, Stamatia; Garantziotis, Panayiotis; Vassilakopoulos, Theodoros P; Papageorgiou, Sotirios G; Pappa, Vassiliki; Galanopoulos, Athanasios G; Viniou, Nora; Nakou, Evangelia; Kalafati, Lydia; Chatzidimitriou, Anastasia; Kassiotis, George; Papaemmanuil, Elli; Mitroulis, Ioannis; Kotsianidis, Ioannis

Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter

低甲基化药物的作用机制:内源性逆转录元件处于中心地位

Kordella, Chryssoula; Lamprianidou, Eleftheria; Kotsianidis, Ioannis

Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression

骨髓增生异常综合征的表观遗传治疗与细胞分化有关,与内源性逆转录因子去抑制无关

Anastasiya Kazachenka, George R Young, Jan Attig, Chrysoula Kordella, Eleftheria Lamprianidou, Emmanuela Zoulia, George Vrachiolias, Menelaos Papoutselis, Elsa Bernard, Elli Papaemmanuil, Ioannis Kotsianidis, George Kassiotis

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition

JAK2V617F 点突变可增强慢性骨髓增生性疾病患者单核细胞破骨细胞形成能力,且使其破骨细胞对 JAK2 抑制更敏感

Emmanouil Spanoudakis, Menelaos Papoutselis, Ioanna Bazdiara, Eleftheria Lamprianidi, Xrisa Kordella, Constantinos Tilkeridis, Costas Tsatalas, Ioannis Kotsianidis

Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity

伴有孤立性17q等臂染色体的髓系肿瘤:一种尚未明确定义的实体

Lamprianidou, Eleftheria; Kordella, Chryssoula; Papoutselis, Menelaos; Bezyrgiannidou, Zoi; Nakou, Evangelia; Papamichos, Spyros; Spanoudakis, Emmanouil; Giannopoulos, Andreas; Zoi, Katerina; Kotsianidis, Ioannis